Diagnostic approach of phospholipid-dependent antibodies. State-of-the art lecture.

Haemostasis Pub Date : 1999-01-01 DOI:10.1159/000022494
J Amiral
{"title":"Diagnostic approach of phospholipid-dependent antibodies. State-of-the art lecture.","authors":"J Amiral","doi":"10.1159/000022494","DOIUrl":null,"url":null,"abstract":"<p><p>Recent scientific developments enable to better understand the strong heterogeneity of assay methods for phospholipid (PLP)-dependent antibodies, measured as lupus anticoagulant (LA) or as anti-PLP antibodies (APA). These latter are actually targeted at complexes of beta(2)-glycoprotein I (beta2GPI) and anionic PLP and also react with insolubilized beta2GPI alone in some patients. Although APA present little species specificity for beta2GPI, some of them bind preferentially to complexes of human beta2GPI and PLP. LAs are diagnosed with screening assays (dPT, dRVVT, KCT, APTT); their sensitivity is dependent on the concentration and type of PLPs used. They are either beta2GPI or prothrombin dependent. Based on the antibody-neutralizing capacity of PLP preparations (such as hexagonal phase phosphatidylethanolamine) or their bypassing activity, confirmatory assays enable to confirm LA. LAs and APAs bind to different epitopes on beta2GPI or its complexes with PLP. Major characteristics of APA assays are: the capture antigen (PLPs, beta2GPI source); its optimization and density on micro-ELISA plates; the efficacy of postcoating saturation; the animal serum used for saturation and diluent; the second antibody which must avoid nonspecific interactions; the calibrators proposed and their reference to international standards; the cutoff between the normal and the pathological ranges; the assay sensitivity and overall specificity for APAs. New optimized assays have been developed to meet these criteria. They are designed with PLP-coated plates, saturated first with immunoglobulin-free human serum as a source of beta2GPI, then with goat serum also used in diluent. The cutoff value is determined with at least 200 normal plasma samples (mean + 3 standard deviations or 99th percentiles) and plasma samples from patients without APAs. This approach offers both optimized specificity and sensitivity for testing APAs, along with a good standardization and it helps to measure the true APAs associated with pathology.</p>","PeriodicalId":12910,"journal":{"name":"Haemostasis","volume":"29 2-3","pages":"135-49"},"PeriodicalIF":0.0000,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000022494","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haemostasis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000022494","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Recent scientific developments enable to better understand the strong heterogeneity of assay methods for phospholipid (PLP)-dependent antibodies, measured as lupus anticoagulant (LA) or as anti-PLP antibodies (APA). These latter are actually targeted at complexes of beta(2)-glycoprotein I (beta2GPI) and anionic PLP and also react with insolubilized beta2GPI alone in some patients. Although APA present little species specificity for beta2GPI, some of them bind preferentially to complexes of human beta2GPI and PLP. LAs are diagnosed with screening assays (dPT, dRVVT, KCT, APTT); their sensitivity is dependent on the concentration and type of PLPs used. They are either beta2GPI or prothrombin dependent. Based on the antibody-neutralizing capacity of PLP preparations (such as hexagonal phase phosphatidylethanolamine) or their bypassing activity, confirmatory assays enable to confirm LA. LAs and APAs bind to different epitopes on beta2GPI or its complexes with PLP. Major characteristics of APA assays are: the capture antigen (PLPs, beta2GPI source); its optimization and density on micro-ELISA plates; the efficacy of postcoating saturation; the animal serum used for saturation and diluent; the second antibody which must avoid nonspecific interactions; the calibrators proposed and their reference to international standards; the cutoff between the normal and the pathological ranges; the assay sensitivity and overall specificity for APAs. New optimized assays have been developed to meet these criteria. They are designed with PLP-coated plates, saturated first with immunoglobulin-free human serum as a source of beta2GPI, then with goat serum also used in diluent. The cutoff value is determined with at least 200 normal plasma samples (mean + 3 standard deviations or 99th percentiles) and plasma samples from patients without APAs. This approach offers both optimized specificity and sensitivity for testing APAs, along with a good standardization and it helps to measure the true APAs associated with pathology.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
磷脂依赖性抗体的诊断方法。最先进的讲座。
最近的科学发展使我们能够更好地理解磷脂(PLP)依赖性抗体测定方法的强异质性,如狼疮抗凝剂(LA)或抗PLP抗体(APA)。后者实际上是针对β(2)-糖蛋白I (beta2GPI)和阴离子PLP的复合物,并且在一些患者中也与不溶化的beta2GPI单独反应。虽然APA对beta2GPI的物种特异性不强,但其中一些会优先结合人beta2GPI和PLP的复合物。LAs通过筛选试验(dPT、dRVVT、KCT、APTT)诊断;它们的灵敏度取决于所使用的plp的浓度和类型。它们要么依赖β 2gpi,要么依赖凝血酶原。基于PLP制剂(如六方相磷脂酰乙醇胺)的抗体中和能力或它们的旁路活性,验证性试验能够确认LA。LAs和APAs结合到beta2GPI或其与PLP复合物的不同表位上。APA检测的主要特点是:捕获抗原(PLPs, beta2GPI来源);其在微板上的优化及密度;涂膜后饱和度的有效性;用作饱和和稀释剂的动物血清;第二抗体必须避免非特异性相互作用;提出的校准器及其与国际标准的参照;正常范围与病理范围的分界点;测定APAs的敏感性和总体特异性。为了满足这些标准,已经开发了新的优化分析方法。它们是用plp包被板设计的,首先用无免疫球蛋白的人血清作为beta2GPI的来源,然后用山羊血清作为稀释液。临界值由至少200份正常血浆样本(平均值+ 3个标准差或99个百分位数)和无APAs患者的血浆样本确定。该方法为检测APAs提供了优化的特异性和敏感性,同时具有良好的标准化,有助于测量与病理相关的真实APAs。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction. Comparison of different methods to measure fibrinogen concentration in canine plasma with respect to their sensitivity towards the fibrinogen degradation products X, Y and D. Endothelial function, variables of fibrinolysis and coagulation in smokers and healthy controls. Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient. Factor V (His 1299 Arg) in young Turkish patients with cerebral infarct.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1